DNA (Deoxyribonucleic Acid) and Gene Chip Global Market Analysis 2024


The Global DNA (Deoxyribonucleic Acid) and Gene Chip Market is projected to reach $15.72 billion by 2028, from a value of $7.51 billion in 2022, by registering a CAGR of 13.1% during the forecast period 2022-2028

SKU: ER1082 Category:
© Epson Research 2021
Share this infographic on
Published Year:
Forecast period:
Report Coverage:

Market Trends and analysis of the crucial market segments across North America, Europe, Asia Pacific and Rest of the World.

Report Format:

5 User License

$ 5,500

  • Access to Five users
  • Print upto 5 copies
  • PDF & Excel Formats

Corporate User License

$ 7,000

  • Unlimited users within company
  • Free Yearly update
  • PDF & Excel Formats

The Global DNA (Deoxyribonucleic Acid) and Gene Chip Market is projected to reach $15.72 billion by 2028, from a value of $7.51 billion in 2022, by registering a CAGR of 13.1% during the forecast period. The high prevalence of cancer, increasing adoption of genetic testing, and strong presence of well-established players are the major factors propelling the growth of the market. However, the cost of microarray algorithm procedures is hampering the market growth. Moreover, increasing collaborative research activities and the growth are technological advancements in robotics are creating ample opportunities across the globe.

Recent Developments

In March 2021, Novogene expanded by opening its single-cell sequencing lab in Singapore. The new lab features a facility to provide a complete end-to-end solution of the single cell gene expression services including single-cell experimental design, single cell capture, sequencing, and data analysis.

In Nov 2020, Bio-Rad Laboratories launched Reliance Select cDNA synthesis kit to help researchers efficiently convert RNA to DNA by reverse transcription. Reliance Select cDNA Synthesis Kit is an important addition to Bio-Rad’s genomics portfolio, providing researchers a way to obtain highly sensitive and reproducible results.

In May 2019, MyHeritage launched the MyHeritage DNA Health+Ancestry test. The test provides a new dimension of genetic insight with comprehensive health reports that can empower future health and lifestyle choices.

In July 2019, PathogenDx, Inc. partnered with Zef Scientific in Canada. This partnership will offer Canadian growers, retailers, distributors and regulators the chance to shorten testing and approval times with greater precision, while getting better and safer products to market faster for Canadian patients and consumers.

Competitive Landscape

Thermo Fisher Scientific, Inc, Shanghai Biochip Co Ltd, Perkin Elmer, Inc., Microarrays Inc, Illumina, Inc, Greiner Bio One International GmbH, Biometrix Technology Inc, Agilent Technologies, Novogene, Bio-Rad Laboratories, MyHeritage, PathogenDx, Inc., Savyon Diagnostics, and Merck KGaA are some of the major players in the global DNA (Deoxyribonucleic Acid) and Gene Chip market.


1 Summary
2 Market Overview
2.1 Abstract
2.2 Research Sources
2.3 Research Findings
2.4 Assumptions
3 Market Dynamics
3.1 Drivers & Opportunities
3.2 Restraints & Threats
3.3 Regulatory Affairs
3.4 Supplychain Analysis
3.5 PORTERS Analysis
4 Competitive Landscape
5 DNA (Deoxyribonucleic Acid) and Gene Chip Market by Product
5.1 Consumables
5.2 Instrumentation
6 DNA (Deoxyribonucleic Acid) and Gene Chip Market by Type
6.1 Complementary DNA Microarrays (cDNA)
6.2 Oligonucleotide DNA Microarrays (oDNA)
7 DNA (Deoxyribonucleic Acid) and Gene Chip Market by Treatment Type
7.1 Trauma/Injury Treatment
7.2 Physical Examinations
7.3 Immunization & Vaccination
7.4 Acute Illness Treatment
8 DNA (Deoxyribonucleic Acid) and Gene Chip Market by Application
8.1 Toxicogenomics
8.2 Single Nucleotide Polymorphism (SNP) Analysis
8.3 AgriGenomics
8.4 Proteomics
8.5 Microbial Genotyping
8.6 Gene Expression
8.7 Environmental Control
8.8 Screening and Monitoring of Patient Data during Clinical Trials
8.9 Drug Discovery
8.10 Cancer Diagnosis & Treatment
8.11 Agricultural Biotechnology
8.12 Genetics
8.12.1 DNA Sequencing by Hybridization
8.12.2 Reverse Genetics
8.12.3 Genomic Mismatch Scanning
8.12.4 Functional Genomics
8.12.5 Gene Mapping and Diagnosis
9 DNA (Deoxyribonucleic Acid) and Gene Chip Market by End User
9.1 Hospitals and Diagnostics Centers
9.2 Biotechnology and Pharmaceutical Companies
9.3 Academic & Government Research Institutes
10 DNA (Deoxyribonucleic Acid) and Gene Chip Market by Regions
10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 Rest of the World
11 Company Profiles
11.1 Thermo Fisher Scientific, Inc
11.2 Shanghai Biochip Co Ltd
11.3 Perkin Elmer, Inc.
11.4 Microarrays Inc
11.5 Illumina, Inc
11.6 Greiner Bio One International GmbH
11.7 Biometrix Technology Inc
11.8 Agilent Technologies
11.9 Novogene
11.10 Bio-Rad Laboratories
11.11 MyHeritage
11.12 PathogenDx, Inc.
11.13 Savyon Diagnostics
11.14 Merck KGaA